摘要
2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒-2 (SARS-CoV-2)引起的传染病,在2020年达到大流行的比例。尽管其最初表现为肺炎和急性呼吸窘迫综合征,但目前已明确这些患者中有1 / 3的神经系统也受损。事实上,相当一部分COVID-19患者通过多种机制遭受神经系统损伤,包括缺氧、凝血病、对病毒的免疫反应,以及SARS-CoV-2对内皮细胞、神经元、星形胶质细胞、周细胞和小胶质细胞的直接影响。此外,少数既往健康的人在接种COVID-19疫苗后会出现各种神经系统并发症,而很大一部分COVID-19幸存者会出现长期的神经精神症状。综上所述,COVID-19也是一种神经系统疾病,病毒对神经系统的直接和间接影响对这些患者的发病率和死亡率有显著影响。神经血管单元由内皮细胞、基底膜、血管周围星形胶质细胞、神经元和小胶质细胞组装而成,本文将从神经血管单元的概念出发,对SARS-CoV-2对神经系统的影响进行综述。然后,我们将利用这些信息回顾迄今发表的关于COVID-19神经系统表现、COVID-19后综合征和COVID-19疫苗的数据。
关键词: COVID-19, SARS-CoV-2,神经血管单元,冠状病毒,凝血功能障碍,COVID-19疫苗,COVID-19后
Current Drug Targets
Title:Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical Manifestations
Volume: 23 Issue: 17
关键词: COVID-19, SARS-CoV-2,神经血管单元,冠状病毒,凝血功能障碍,COVID-19疫苗,COVID-19后
摘要: Coronavirus Disease 2019 (COVID-19) is an infectious disease, caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), that reached pandemic proportions in 2020. Despite the fact that it was initially characterized by pneumonia and acute respiratory distress syndrome, it is now clear that the nervous system is also compromised in one third of these patients. Indeed, a significant proportion of COVID-19 patients suffer nervous system damage via a plethora of mechanisms including hypoxia, coagulopathy, immune response to the virus, and the direct effect of SARS-CoV-2 on endothelial cells, neurons, astrocytes, pericytes and microglia. Additionally, a low number of previously healthy individuals develop a variety of neurological complications after receiving COVID-19 vaccines and a large proportion of COVID-19 survivors experience longlasting neuropsychiatric symptoms. In conclusion, COVID-19 is also a neurological disease, and the direct and indirect effects of the virus on the nervous system have a significant impact on the morbidity and mortality of these patients. Here we will use the concept of the neurovascular unit, assembled by endothelial cells, basement membrane, perivascular astrocytes, neurons and microglia, to review the effects of SARS-CoV-2 in the nervous system. We will then use this information to review data published to this date on the neurological manifestations of COVID-19, the post- COVID syndrome and COVID-19 vaccines.
Export Options
About this article
Cite this article as:
Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical Manifestations, Current Drug Targets 2022; 23 (17) . https://dx.doi.org/10.2174/1389450123666220919123029
DOI https://dx.doi.org/10.2174/1389450123666220919123029 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Perspectives for Drug Intervention in Amyloid Diseases
Current Drug Targets Modulation of Human Keratinocyte Responses to Solar UV by Plant Polyphenols As a Basis for Chemoprevention of Non-Melanoma Skin Cancers
Current Medicinal Chemistry Pathways Related to the Anti-Cancer Effects of Metabolites Derived from Cerrado Biome Native Plants: An Update and Bioinformatics Analysis on Oral Squamous Cell Carcinoma
Protein & Peptide Letters Vitamin D and Infectious Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Central Anti-Cholinergic Syndrome Induced by Single Therapeutic Dose of Atropine
Current Drug Safety The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases
Current Pharmaceutical Design Effect of Tetracyclines on IgE Allergic Responses and Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring
Current Proteomics Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?
Current Cancer Drug Targets Highly Selective Phosphodiesterase 4 Inhibitors for the Treatment of Allergic Skin Diseases and Psoriasis
Inflammation & Allergy - Drug Targets (Discontinued) About the Guest Editors
Recent Patents on Inflammation & Allergy Drug Discovery Safety of Using Copper Oxide in Medical Devices and Consumer Products
Current Chemical Biology Multiple Roles of Fibroblast Growth Factor 21 in Metabolism
Current Pharmaceutical Design Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety The Relevance of JAK2 in the Regulation of Cellular Transport
Current Medicinal Chemistry Structural, Functional and Therapeutic Aspects of Snake Venom Metalloproteinases
Mini-Reviews in Organic Chemistry Editorial [ Advances in Heme Oxygenase Research as a Potential Therapeutic Strategy Executive Editor: M.J. Alcaraz]
Current Pharmaceutical Design Editorial [Hot Topic: Granulocyte Toxicity in the Lung (Guest Editor: Hannu Kankaanranta)]
Current Drug Targets - Inflammation & Allergy Liposomes as Nanovaccine Delivery Systems
Current Topics in Medicinal Chemistry Regulation of Ocular Immune Responses by Corneal Epithelium
Current Immunology Reviews (Discontinued)